Gary Chmielewski to Neoplasm Staging
This is a "connection" page, showing publications Gary Chmielewski has written about Neoplasm Staging.
Connection Strength
0.171
-
Positron-emission tomography as a prognostic tool for early-stage lung cancer. Am J Surg. 2006 Mar; 191(3):433-6.
Score: 0.057
-
Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening. Lung. 2019 06; 197(3):327-332.
Score: 0.035
-
Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
Score: 0.026
-
Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1344-50; discussion 1350-1.
Score: 0.022
-
Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20; 28(6):928-35.
Score: 0.019
-
Lysyl oxidase expression in bronchogenic carcinoma. Am J Surg. 2005 Mar; 189(3):297-301.
Score: 0.013